Clinical Radiological Technologist Training and Education Facility Established at a University in the United States (MSU) ‒ The first Corporate Sponsored Radiologic Science Program in the United States ‒ Read more
Technology brings university scientists unparalleled potential for chemical, biological and human disease research First commercial research instrument of its kind in the world. MILFORD, Mass.–(BUSINESS WIRE)–Nov. 7, 2019– Aston University and Waters Corporation (NYSE: WAT) announced today the completed installation of the world’s first Waters™ SELECT SERIES™ Cyclic™ IMS (ion mobility spectrometry) mass spectrometer within the University’s School of Health and Life... Read more
Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral presentations, across a range of 15 blood cancers and non-malignant haematological conditions New data for CD20-CD3... Read more
AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). Comparisons shown in this release are to the same period in the prior year unless otherwise noted. CURRENT... Read more
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products Chalfont St Giles, UK – November 4 2019 – The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast... Read more
New ZEISS iCeMS Innovation Core collaborative laboratory opened Topics Press Release About ZEISS Press Photos Further Articles Jena/Germany, Kyoto/Japan | 30 October 2019 | ZEISS Research Microscopy Solutions ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement. As part of the agreement, the partners are opening the ZEISS iCeMS... Read more
Roche announced today that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for satralizumab for the treatment of adult and adolescent patients with neuromyelitis optica spectrum disorder (NMOSD), granting it Accelerated Assessment. Validation confirms that the submission is complete and signifies the MAA is under review by the EMA’s Committee... Read more
Thermo Fisher Scientific Launches Cell Culture Media as First to Remain Stable When Stored at Room Temperature Storing at room temperature offers labs greater flexibility and requires less energy CARLSBAD, Calif., Oct. 21, 2019 /PRNewswire/ — For biological researchers looking to reduce their reliance on cold storage without disrupting their existing workflow, Thermo Fisher Scientific’s new... Read more
Basel, 18 October 2019 Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control and Prevention (CDC) defines people at... Read more